PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10614786-4	1999	Three tyrosine kinases inhibitors, ST-638, methyl 2,5-dihydroxycinnamate, and genistein reduced fMLP-stimulated PLD activity by up to 80%.	methyl 2,5-dihydroxycinnamate	43-72	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	112-115	
7526916-4	1994	PLD was activated in response to 0.3 U/ml thrombin, and this activation was reduced by several of the PTK inhibitors, especially genistein, methyl 2,5-dihydroxycinnamate (MDHC), ST271, and the tyrphostins A25 and A47.	methyl 2,5-dihydroxycinnamate	140-169	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	0-3	
7526916-4	1994	PLD was activated in response to 0.3 U/ml thrombin, and this activation was reduced by several of the PTK inhibitors, especially genistein, methyl 2,5-dihydroxycinnamate (MDHC), ST271, and the tyrphostins A25 and A47.	methyl 2,5-dihydroxycinnamate	171-175	glycosylphosphatidylinositol specific phospholipase D1	Homo sapiens	0-3